NIH-funded research NIH-funded research

Understanding how Eph receptors help cells communicate

Official title: Molecular mechanisms of Eph receptor signaling

Funded at Ohio State University · NIH-10938787 · Data updated 2026-11-12

This study is looking at how certain proteins help cells talk to each other, which is important for our health, especially in conditions like cancer and brain diseases, using special tools to see how these proteins work in human cells.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startJuly 15, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$297,513
NIH project number1R35GM154813-01
Project IDNIH-10938787 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions related to cell signaling abnormalities, particularly those with cancer or neurodegenerative diseases.

Less likely to help

Patients with conditions unrelated to cell signaling or those who do not have any known genetic or biochemical disorders may not benefit from this research.

What this research studies

This research investigates the molecular mechanisms behind how Eph receptors, a type of protein involved in cell signaling, facilitate communication between cells. By utilizing advanced techniques such as optogenetics and single-molecule microscopy, the research aims to uncover the processes that regulate the clustering of these receptors, which is crucial for various biological functions. The study focuses on human cells and seeks to provide insights into how these mechanisms are linked to health conditions like cancer and neurodegeneration.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases related to cell communication, such as cancer.

How similar studies have gone: Previous research has shown promising results in understanding cell signaling mechanisms, making this approach both relevant and potentially impactful.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Belyy, Vladislav — Ohio State University
  • Study coordinator: Belyy, Vladislav

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.